Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications.
暂无分享,去创建一个
[1] J. Halperin,et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.
[2] W. Manning,et al. Transesophageal Echocardiography and Atrial Fibrillation: Added Value or Expensive Toy? , 1998, Annals of Internal Medicine.
[3] Y. Adler,et al. Association between mitral annular calcium and aortic atheroma as detected by transesophageal echocardiographic study. , 1998, The American journal of cardiology.
[4] M. Senni,et al. Fibrinogen is an independent marker for thoracic aortic atherosclerosis. , 1998, The American journal of cardiology.
[5] S. Humphries,et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. , 1997, Circulation.
[6] S. Nagueh,et al. Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography. , 1997, Journal of the American College of Cardiology.
[7] Strokepreventioninatrialfibri. The stroke prevention in atrial fibrillation III study: rationale, design, and patient features. , 1997, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[8] I. Kronzon,et al. Atheromatous Disease of the Thoracic Aorta: Pathologic and Clinical Implications , 1997, Annals of Internal Medicine.
[9] R. Sacco,et al. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. , 1996, The New England journal of medicine.
[10] J. Gold,et al. Severity of Aortic Atheromatous Disease Diagnosed by Transesophageal Echocardiography Predicts Stroke and Other Outcomes Associated with Coronary Artery Surgery: A Prospective Study , 1996, Anesthesia and analgesia.
[11] W. J. Hamilton,et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.
[12] F. Cambien,et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. , 1996, Circulation.
[13] R. Sacco,et al. Aortic atheromas and acute ischemic stroke , 1996, Neurology.
[14] J. Lodder,et al. Risk of stroke in a cohort of 815 patients with calcification of the aortic valve with or without stenosis. , 1996, Stroke.
[15] S. Litin,et al. Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment. , 1996, Mayo Clinic proceedings.
[16] K. D. Hopkins,et al. Aortic distensibility in patients with cerebrovascular disease. , 1995, Clinical science.
[17] W. Manning,et al. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. , 1995, Circulation.
[18] M. Kotler,et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. , 1995, The New England journal of medicine.
[19] S. Capomolla,et al. Cardiac and vascular sources of peripheral thromboembolism in patients with atrial fibrillation. A combined transesophageal and vascular ultrasonographic study. , 1995, Giornale italiano di cardiologia.
[20] A. Tonkin,et al. Proximal aortic atheroma. An independent risk factor for cerebral ischemia. , 1995, Stroke.
[21] N. Kouchoukos,et al. Atherosclerosis of the Ascending Aorta: Prevalence and Role as an Independent Predictor of Cerebrovascular Events in Cardiac Patients , 1994, Stroke.
[22] D. Leung,et al. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. , 1994, Journal of the American College of Cardiology.
[23] H. Schunkert,et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.
[24] I. Kronzon,et al. High Risk for Vascular Events in Patients with Protruding Aortic Atheromas: A Prospective Study , 1994, Journal of the American College of Cardiology.
[25] J. Rothrock,et al. Ischemic stroke in patients with atrial fibrillation , 1993, Neurology.
[26] K. Toyoda,et al. Aortogenic Embolic Stroke: A Transesophageal Echocardiographic Approach , 1992, Stroke.
[27] C. Duyckaerts,et al. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. , 1992, The New England journal of medicine.
[28] I. Kronzon,et al. Protruding atheromas in the thoracic aorta and systemic embolization. , 1991, Annals of internal medicine.
[29] I. Kronzon,et al. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. , 1990, American heart journal.
[30] W. Aronow,et al. Association of mitral annular calcium with new thromboembolic stroke at 44-month follow-up of 2,148 persons, mean age 81 years. , 1998, The American journal of cardiology.
[31] Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. , 1998, Archives of internal medicine.
[32] Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial Fibrillation , 1998, Annals of Internal Medicine.
[33] C. Doherty,et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. , 1997, Stroke.
[34] Transesophageal echocardiography in atrial fibrillation: standards for acquisition and interpretation and assessment of interobserver variability. Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[35] T Moulin,et al. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. , 1996, The New England journal of medicine.
[36] J. Kistler,et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. , 1995, The New England journal of medicine.
[37] J. Rothrock,et al. Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. , 1994, Archives of internal medicine.
[38] Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. , 1994, Archives of internal medicine.
[39] J. Ross,et al. Recognition and embolic potential of intraaortic atherosclerotic debris. , 1991, Journal of the American College of Cardiology.
[40] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.